CONMED Corp (CNMD) stock
CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3029% below fair value
$48.39−0.96 (-1.95%)
Close on Nov 17, 2026Market cap $1.44BP/E 20.0Yield 1.24%
Conmed total assets
Total assets on the balance sheet at the end of each period.
Conmed's total assets was $2.30B at Sep 30, 2026. For fiscal 2025 it was $2.33B, up 0.8% from the year before. Over ten years it grew 7.8% a year on average. The highest annual figure on record is $2.33B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.33B | +0.8% |
| FY2024 | Dec 31, 2024 | $2.31B | +0.3% |
| FY2023 | Dec 31, 2023 | $2.30B | +0.1% |
| FY2022 | Dec 31, 2022 | $2.30B | +30.1% |
| FY2021 | Dec 31, 2021 | $1.77B | +0.8% |
| FY2020 | Dec 31, 2020 | $1.75B | -1.3% |
| FY2019 | Dec 31, 2019 | $1.78B | +29.7% |
| FY2018 | Dec 31, 2018 | $1.37B | +0.8% |
| FY2017 | Dec 31, 2017 | $1.36B | +2.2% |
| FY2016 | Dec 31, 2016 | $1.33B | +20.6% |
| FY2015 | Dec 31, 2015 | $1.10B | +0.3% |
| FY2014 | Dec 31, 2014 | $1.10B | +0.7% |
| FY2013 | Dec 31, 2013 | $1.09B | +1.1% |
| FY2012 | Dec 31, 2012 | $1.08B | +15.3% |
| FY2011 | Dec 31, 2011 | $935.59M | -5.1% |
| FY2010 | Dec 31, 2010 | $985.77M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.30B | -0.8% |
| Q2 FY2026 | Jun 30, 2026 | $2.30B | -1.2% |
| Q1 FY2026 | Mar 31, 2026 | $2.31B | +0.8% |
| Q4 FY2025 | Dec 31, 2025 | $2.33B | +0.8% |
| Q3 FY2025 | Sep 30, 2025 | $2.32B | +0.3% |
| Q2 FY2025 | Jun 30, 2025 | $2.33B | +1.9% |
| Q1 FY2025 | Mar 31, 2025 | $2.30B | -0.5% |
| Q4 FY2024 | Dec 31, 2024 | $2.31B | +0.3% |
| Q3 FY2024 | Sep 30, 2024 | $2.32B | -0.4% |
| Q2 FY2024 | Jun 30, 2024 | $2.29B | -1.6% |
| Q1 FY2024 | Mar 31, 2024 | $2.31B | -0.5% |
| Q4 FY2023 | Dec 31, 2023 | $2.30B | +0.1% |
| Q3 FY2023 | Sep 30, 2023 | $2.33B | +1.5% |
| Q2 FY2023 | Jun 30, 2023 | $2.32B | +12.1% |
| Q1 FY2023 | Mar 31, 2023 | $2.32B | +29.9% |
| Q4 FY2022 | Dec 31, 2022 | $2.30B | +30.1% |
| Q3 FY2022 | Sep 30, 2022 | $2.29B | +30.7% |
| Q2 FY2022 | Jun 30, 2022 | $2.07B | +17.6% |
| Q1 FY2022 | Mar 31, 2022 | $1.79B | +2.2% |
| Q4 FY2021 | Dec 31, 2021 | $1.77B | +0.8% |
| Q3 FY2021 | Sep 30, 2021 | $1.75B | +0.6% |
| Q2 FY2021 | Jun 30, 2021 | $1.76B | +2.2% |
| Q1 FY2021 | Mar 31, 2021 | $1.75B | -0.2% |
| Q4 FY2020 | Dec 31, 2020 | $1.75B | -1.3% |
| Q3 FY2020 | Sep 30, 2020 | $1.74B | -0.9% |
| Q2 FY2020 | Jun 30, 2020 | $1.72B | -2.0% |
| Q1 FY2020 | Mar 31, 2020 | $1.75B | -0.6% |
| Q4 FY2019 | Dec 31, 2019 | $1.78B | +29.7% |
| Q3 FY2019 | Sep 30, 2019 | $1.76B | +29.0% |
| Q2 FY2019 | Jun 30, 2019 | $1.76B | +29.0% |
| Q1 FY2019 | Mar 31, 2019 | $1.76B | +30.4% |
| Q4 FY2018 | Dec 31, 2018 | $1.37B | +0.8% |
| Q3 FY2018 | Sep 30, 2018 | $1.36B | +0.1% |
| Q2 FY2018 | Jun 30, 2018 | $1.36B | +2.1% |
| Q1 FY2018 | Mar 31, 2018 | $1.35B | +1.7% |
| Q4 FY2017 | Dec 31, 2017 | $1.36B | +2.2% |
| Q3 FY2017 | Sep 30, 2017 | $1.36B | – |
| Q2 FY2017 | Jun 30, 2017 | $1.34B | – |
| Q1 FY2017 | Mar 31, 2017 | $1.33B | – |
| Q4 FY2016 | Dec 31, 2016 | $1.33B | – |
See a number that looks wrong?